Abdel-Magid, A. F. (2019). LRRK2 Kinase Inhibitors as Possible Therapy for Parkinson’s Disease and Other Neurodegenerative Disorders. ACS Med Chem Lett.
Chicago Stili AlıntıAbdel-Magid, Ahmed F. "LRRK2 Kinase Inhibitors As Possible Therapy for Parkinson’s Disease and Other Neurodegenerative Disorders." ACS Med Chem Lett 2019.
MLA AlıntıAbdel-Magid, Ahmed F. "LRRK2 Kinase Inhibitors As Possible Therapy for Parkinson’s Disease and Other Neurodegenerative Disorders." ACS Med Chem Lett 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..